Presentation is loading. Please wait.

Presentation is loading. Please wait.

Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding  Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,

Similar presentations


Presentation on theme: "Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding  Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,"— Presentation transcript:

1 Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding 
Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk, PharmD, PhD, Khanchit Likittanasombat, MD, MRCP, Surakit Nathisuwan, PharmD, BCPS  Value in Health Regional Issues  Volume 1, Issue 1, Pages (May 2012) DOI: /j.vhri Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2 Fig. 1 Porportion of acute coronary syndrome patients included in the study. STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; UA, unstable angina. Value in Health Regional Issues 2012 1, 41-45DOI: ( /j.vhri ) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions


Download ppt "Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding  Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,"

Similar presentations


Ads by Google